Drawing for BIO CITY

USPTO serial 79413796

BIO CITY

Reviewed by CopyMark Law Group

Reg. 8054803Status 700Registered
Filing date
Status date
Registration date
Dec 9, 2025
Examiner
KAJUBI, ELIZABETH N
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with BIO CITY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John Zaccaria

John Zaccaria Notaro, Michalos & Zaccaria P.C.100 Dutch Hill Road, Suite 240Orangeburg, NY 10962United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, namely, for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; drugs for medical purposes, namely pharmaceutical preparations for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; biological preparations for medical purposes, namely, for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; biological tissue cultures for medical purposes, namely, for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; chemical preparations for medical purposes, namely, for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19.ACTIVE—
042Scientific and technological services and research and design relating thereto, namely, research and design in the field of products and processes development of biotechnology products and processes; bacteriological research; biological research; chemistry services in the nature of product development and quality control of biotechnology products; chemical research; Scientific research in the nature of conducting clinical trials for others; scientific research; medical research; scientific laboratory services; technological research in the field of development of manufacturing processes for biotechnology products for pharmaceutical use; technological consultancy in the field of development of manufacturing processes for biotechnology productsACTIVE—
044Medical services; alternative medicine services; in vitro fertilization services; occupational therapy services; human tissue bank services; rental of medical equipment; medical analysis services for diagnostic and treatment purposes provided by medical laboratories.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 9, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 21, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 21, 2026FIMPFINAL DISPOSITION PROCESSED—
Jun 18, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jun 1, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 31, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Mar 9, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 9, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 9, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 21, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 21, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 15, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 19, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 12, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 12, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 12, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 5, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 5, 2025ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Sep 5, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 5, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 5, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 5, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 17, 2025RFNTREFUSAL PROCESSED BY IB—
Apr 27, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 27, 2025RFRRREFUSAL PROCESSED BY MPU—
Mar 15, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 14, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 11, 2025DOCKASSIGNED TO EXAMINER—
Jan 21, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 21, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 21, 2025LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Jan 2, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance